Total (n = 60) | Follow up for MACE | Test of sig. | p | ||
---|---|---|---|---|---|
Absent (n = 55) | Present (n = 5) | ||||
Sex | |||||
Female | 6 (10%) | 4 (7.3%) | 2 (40.0%) | χ2 = 5.455* | 0.020* |
Male | 54 (90%) | 51 (92.7%) | 3 (60.0%) | ||
Age (years) | |||||
Mean ± SD | 51.6 ± 10.1 | 51 ± 10.1 | 58.4 ± 8.4 | t = 1.596 | 0.116 |
Median (Min.–Max) | 53.5 (26–70) | 51 (26–70) | 60 (47–70) | ||
Diabetes mellitus | 20 (33.3%) | 15 (27.3%) | 5 (100.0%) | χ2 = 10.909* | 0.001* |
Hypertension | 20 (33.3%) | 17 (30.9%) | 3 (60.0%) | χ2 = 1.745 | 0.186 |
CKD | 9 (15.0%) | 6 (10.9%) | 3 (60.0%) | χ2 = 8.663* | 0.003* |
Dyslipidemia | 23 (38.3%) | 19 (34.5%) | 4 (80.0%) | χ2 = 4.006 | 0.045* |
Smoking (current) | 51 (85.0%) | 49 (89.1%) | 2 (40.0%) | χ2 = 8.663* | 0.003* |
Smoking (former) | 2 (3.3%) | 2 (3.6%) | 0 (0.0%) | χ2 = 0.188 | 0.665 |
Alcohol | 2 (3.3%) | 2 (3.6%) | 0 (0.0%) | χ2 = 0.188 | 0.665 |
Family history of CAD | 18 (30.0%) | 18 (32.7%) | 0 (0.0%) | χ2 = 2.338 | 0.126 |
Hemoglobin level (g/dl) | |||||
Mean ± SD | 13.5 ± 2.1 | 13.7 ± 2 | 11.5 ± 1.6 | t = 2.412* | 0.019* |
Median (Min.–Max) | 14 (8.5–16) | 14 (8.5–16) | 12 (9–13.4) | ||
S. Creatinine (mg/dl) | |||||
Mean ± SD | 1 ± 0.8 | 1 ± 0.9 | 1 ± 0.1 | U = 62.0* | 0.042* |
Median (Min.–Max) | 0.9 (0.5–7) | 0.9 (0.5–7) | 1.1 (0.9–1.2) | ||
Positive Troponin | 60 (100%) | 55 (100%) | 5 (100%) | – | – |
LDL level (mg/dl) | |||||
Mean ± SD | 118 ± 24.1 | 115.8 ± 23.2 | 142.8 ± 20.4 | t = 2.511* | 0.015* |
Median (Min.–Max) | 109.5 (86–177) | 107 (86–177) | 143 (111–165) |